InMed Pharmaceuticals Inc. Common Shares

INMNASDAQ • USD
ThemeBiotech - Drug Development›Rare Disease Therapeutics
1.30 USD
↗ 0.01 (0.78%)AT CLOSE (11:59 AM EDT)
1.30
↗ 0.00 (0.00%)
POST MARKET (AS OF 04:10 PM EDT)
Post Market
AS OF 04:10 PM EDT
1.30
↗ 0.00 (0.00%)
🟢Market: OPEN

InMed Pharmaceuticals Inc. Common Shares (INM) is currently trading at $1.30. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place INM at a fair price relative to peers.

Technical & fundamental data as of Sep 14, 2026.

Open?$1.29
High?$1.32
Low?$1.27
Prev. Close?$1.29
Volume?58.5K
Avg. Volume?79.5K
VWAP?$1.30
Rel. Volume?0.74x
Bid / Ask
Bid?$1.04 × 100
Ask?$1.53 × 100
Spread?$0.49
Midpoint?$1.29
Valuation & Ratios
Market Cap?7.1M
Shares Out?5.5M
Float?3.3M
Float %?99.2%
P/E Ratio?N/A
P/B Ratio?6.59
EPS?-$2.36
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
Themes
Biotech - Drug Development›Rare Disease TherapeuticsCannabis›CBD & Hemp Products
Employees
6
Market Cap
7.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.inmedpharma.com
Listed
2020-11-10
Address
C/O NORTON ROSE FULBRIGHT CANADA LLP
VANCOUVER, V6B 0M3
Phone: (604) 669-7207
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
23
Short Sent.?
80
Piotroski F-Score?0/9Weak
Altman Z-Score?-67.82Distress
Confidence?43%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.94%Low
Short Interest?30.8K
Days to Cover?1.0
Free Float3.3M
Avg Daily Volume102.1K
Settlement Date2026-08-31
Financial Health
Current Ratio?1.45Adequate
Quick Ratio?1.45Adequate
Cash Ratio?1.19Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
28
6.59FAIR▾
P/S?
Peers
100
S&P
42
3.65FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.5CHEAP▾
EV/Sales?
Peers
100
S&P
67
2.52CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-1,208.6%WEAK▾
ROA?
S&P
3
-428.8%WEAK▾
Cash Flow & Enterprise
FCF?$-8643513
Enterprise Value?$4.9M
Fundamentals ratios updated end of day
MarketsMoversWatchlist